The FDA said the expanded access pathway will not be used to make a vaccine available for children unless safety and immunogenicity data in that group is available. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
